These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
236 related items for PubMed ID: 21330855
61. Arginine vasopressin in advanced vasodilatory shock. De Backer D, Creteur J, Vincent JL. Circulation; 2003 Nov 11; 108(19):e142; author reply e142. PubMed ID: 14610005 [No Abstract] [Full Text] [Related]
62. [Drug therapy of cardiogenic shock. Improvement in hemodynamics is essential]. Stiefelhagen P. Med Monatsschr Pharm; 2010 Aug 11; 33(8):303-5. PubMed ID: 21189650 [No Abstract] [Full Text] [Related]
63. Baycain as a blocking agent in ocular surgery. el-Araba M, Abdalla MI. Bull Ophthalmol Soc Egypt; 1965 Aug 11; 58(62):191-4. PubMed ID: 5876292 [No Abstract] [Full Text] [Related]
65. [Vasopressor drugs in shock due to myocardial infarction]. Adamska-Dyniewska H. Pol Tyg Lek; 1967 Oct 02; 22(45):1744-7. PubMed ID: 4294154 [No Abstract] [Full Text] [Related]
66. [Infusion treatment in shock]. Esser H. Infusionsther Klin Ernahr; 1975 Dec 02; 2(6):424-8. PubMed ID: 1344 [Abstract] [Full Text] [Related]
67. Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock. How OJ, Røsner A, Kildal AB, Stenberg TA, Gjessing PF, Hermansen SE, Myrmel T. Transl Res; 2010 Nov 02; 156(5):273-81. PubMed ID: 20970750 [Abstract] [Full Text] [Related]
70. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Potter BJ. N Engl J Med; 2021 Nov 25; 385(22):2107-2108. PubMed ID: 34818493 [No Abstract] [Full Text] [Related]
71. Cardiogenic shock. Loeb HS, Johnson SA, Gunnar RM. Triangle; 1974 Nov 25; 13(3):121-7. PubMed ID: 4614505 [No Abstract] [Full Text] [Related]
72. Comparison of dopamine and norepinephrine in shock. Du B, Hu X, Weng L. N Engl J Med; 2010 Jun 17; 362(24):2330; author reply 2330-1. PubMed ID: 20560182 [No Abstract] [Full Text] [Related]
73. Treatment of cardiogenic shock. I. Cohen LS. Md State Med J; 1972 Sep 17; 21(9):26-8. PubMed ID: 5054523 [No Abstract] [Full Text] [Related]
74. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Gibson LE, Chang MG, Berra L. N Engl J Med; 2021 Nov 25; 385(22):2108. PubMed ID: 34818494 [No Abstract] [Full Text] [Related]
75. [Hepatic venous and mixed venous O2 saturation during catecholamine therapy in patients with septic shock]. Meier-Hellmann A, Hannemann L, Specht M, Spies C, Reinhart K. Anaesthesist; 1993 Jan 25; 42(1):29-33. PubMed ID: 8447569 [Abstract] [Full Text] [Related]
76. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Reply. Mathew R, Di Santo P, Hibbert B. N Engl J Med; 2021 Nov 25; 385(22):2108-2109. PubMed ID: 34818495 [No Abstract] [Full Text] [Related]
77. Treatment of hypotension in septic shock. Stewart JT. Lancet; 1996 Mar 02; 347(9001):622-3. PubMed ID: 8596356 [No Abstract] [Full Text] [Related]
78. [Use of dobutamine in the treatment of post-infarction shock]. Trojnar R, Kutarski A, Kedra WA, Rymar B, Markiewicz M. Wiad Lek; 1983 Apr 01; 36(7):531-6. PubMed ID: 6349132 [No Abstract] [Full Text] [Related]
79. Pharmacologic interventions in resuscitation. Boike SC, Rybak MJ. Emerg Med Clin North Am; 1983 Dec 01; 1(3):553-69. PubMed ID: 6396072 [Abstract] [Full Text] [Related]
80. [Treatment of immediate drug hypersensitivity]. Plaut M, Lichtenstein LM. Internist (Berl); 1975 Feb 01; 16(2):68-74. PubMed ID: 1091590 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]